Israeli Hospitals Destroy Tumors With Liquid Nitrogen
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
Related Articles
Special Maternity Lounge for New Mothers
Approximately 9,000 babies are born at the Helen Schneider Hospital for Women yearly and about seven percent of these are premature deliveries where the baby is still hospitalized after the mother goes home.
Radiologist Wins Prestigious Nash Foundation Grant
Dr. Gideon Shafir, senior radiologist at the Rabin Medical Center,
won a Nash Foundation grant for a visiting fellowship in cardiovascular
imaging at Stanford University.
Israeli Cardiothoracic Surgeons Visit India
Dr. Eyal Porat, recently returned from India where he was part of a prestigious group representing Israel in the fields of medicine, culture, sports and culinary arts.